Michael J. Birrer

University of Arkansas for Medical Sciences

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

1in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Papers

Driven by 3 papers. Top paper: “Weekly vs. Every-3-Week Paclitaxel and Carboplatin for Ovarian Cancer”.

Weekly vs. Every-3-Week Paclitaxel and Carboplatin for Ovarian Cancer

New England Journal of Medicine(2016)10.1056/nejmoa1505067

N/A

0.886DataRank · unranked

367 citations

Mark F. Brady, Richard T. Penson, Helen Huang, Michael J. Birrer, Joan L. Walker +10 more

Multiomic analysis identifies CPT1A as a potential therapeutic target in platinum-refractory, high-grade serous ovarian cancer

Cell Reports Medicine(2021)10.1016/j.xcrm.2021.100471

N/A

0.652DataRank · unranked

76 citations

Shrabanti Chowdhury, Hong Wang, Sara R. Savage, Richard G. Ivey, Jacob J. Kennedy +25 more

Understanding the effect of mechanical forces on ovarian cancer progression

Gynecologic Oncology(2021)10.1016/j.ygyno.2021.04.003

N/A

0DataRank · unranked

22 citations

Molly Buckley, Carly Bess Scalise, Ashwini A. Katre, Jhalak Dholakia, David K. Crossman +4 more